Anti-neutrophil Cytoplasmic Antibody-Associated Glomerulonephritis Secondary to Hydralazine: A Case Report
Open Access
- 15 December 2022
- journal article
- research article
- Published by Springer Nature in Cureus
- Vol. 14 (12) , e32603
Abstract
Hydralazine is a vasodilator used in the treatment of resistant hypertension. It is a safe and widely used antihypertensive medicine. Its common adverse effects include headache, rebound tachycardia, fluid retention, and angina. It is a rare cause of anti-neutrophil cytoplasmic antibody (ANCA) associated vasculitis (AAV) with pulmonary and renal involvement. We report a case of a 74-year-old woman, with over eight years of use of hydralazine, who presented to the hospital with shortness of breath and cough. Blood work revealed deranged renal function with high creatinine levels. Serology workup was positive for anti-histone antibodies (AHA), anti-nuclear antibodies (ANA), myeloperoxidase (MPO) ANCA and proteinase-3 (PR-3) ANCA. Renal biopsy showed diffusely flattened tubular epithelium, focal micro vesicular degeneration, and focal loss of the brush border of the proximal tubular epithelium. Hydralazine was stopped and the patient was treated with corticosteroids, resulting in the resolution of her kidney injury.Keywords
This publication has 15 references indexed in Scilit:
- Hydralazine-Induced ANCA Associated Vasculitis (AAV) Presenting with Pulmonary-Renal Syndrome (PRS): A Case Report with Literature ReviewCurrent Cardiology Reviews, 2021
- Hydralazine-Induced Antineutrophil Cytoplasmic Antibody-Associated Vasculitis: Asymptomatic and Renal-Restricted PresentationAmerican Journal of Case Reports, 2021
- Hydralazine-Induced Dual Antineutrophil Cytoplasmic Antibody Positive Vasculitis and NephritisCureus, 2020
- Hydralazine-induced antineutrophil cytoplasmic antibody-associated vasculitis with pulmonary–renal syndrome: a case reportJournal of Medical Case Reports, 2020
- Successful use of rituximab for hydralazine-induced anti-neutrophil cytoplasmic antibodies-associated vasculitisSaudi Journal of Kidney Diseases and Transplantation, 2019
- Hydralazine-associated antineutrophil cytoplasmic antibody vasculitis with pulmonary–renal syndromeBMJ Case Reports, 2018
- Hydralazine-induced MPO-ANCA Renal-Limited Vasculitis Masquerading as Lupus NephritisJournal of the College of Physicians and Surgeons Pakistan, 2018
- Hydralazine-associated vasculitis: Overlapping features of drug-induced lupus and vasculitisSeminars in Arthritis and Rheumatism, 2018
- Hydralazine-associated adverse events: a report of two cases of hydralazine-induced ANCA vasculitisBrazilian Journal of Nephrology, 2018
- Hydralazine-induced pauci-immune glomerulonephritis: intriguing case series with misleading diagnosesJournal of Community Hospital Internal Medicine Perspectives, 2016